1. Use of a levonorgestrel-releasing intrauterine system to treat bleeding related to uterine leiomyomas 
Vera Grigorieva, MD, Mario Chen-Mok, PhD, Marina Tarasova, MD, PhD, Anton Mikhailov, MD, PhD 
Fertility and Sterility 
Volume 79, Issue 5, Pages (May 2003)
DOI: /S (03)

2. FIGURE 1
Estimated menstrual blood loss (mean ± SD) before and after insertion of the levonorgestrel-releasing intrauterine system. *P<.001 vs. baseline; PBAC = pictorial blood loss assessment chart.
Grigorieva. Levonorgestrel IUS in women with leiomyoma. Fertil Steril 2003.
Fertility and Sterility  , DOI: ( /S (03) )

3. FIGURE 2
Blood hemoglobin level (mean ± SD) before and after insertion of the levonorgestrel-releasing intrauterine system. *P<.001 vs. baseline.
Grigorieva. Levonorgestrel IUS in women with leiomyoma. Fertil Steril 2003.
Fertility and Sterility  , DOI: ( /S (03) )

4. FIGURE 3
Serum ferritin level (mean ± SD) before and after insertion of the levonorgestrel-releasing intrauterine system. *P<0.001 vs. baseline.
Grigorieva. Levonorgestrel IUS in women with leiomyoma. Fertil Steril 2003.
Fertility and Sterility  , DOI: ( /S (03) )